Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 13,627,000 | 13,045,000 | 13,147,000 | 13,005,000 | 14,047,000 |
Cost of Goods | 3,212,000 | 3,085,000 | 3,174,000 | 2,851,000 | 3,411,000 |
Gross Profit | 10,415,000 | 9,960,000 | 9,973,000 | 10,154,000 | 10,636,000 |
Operating Expenses | 8,659,000 | 6,939,000 | 6,496,000 | 6,263,000 | 8,802,000 |
Operating Income | 1,756,000 | 3,021,000 | 3,477,000 | 3,891,000 | 1,834,000 |
Other Income | -980,000 | -1,417,000 | -1,067,000 | -330,000 | -2,187,000 |
Pre-tax Income | 776,000 | 1,604,000 | 2,410,000 | 3,561,000 | -353,000 |
Income Tax | 14,000 | 249,000 | 347,000 | 513,000 | -188,000 |
Net Income Continuous | 764,000 | 1,355,000 | 2,062,000 | 3,048,000 | -166,000 |
Net Income Discontinuous | 15,000 | N/A | 1,000 | N/A | -3,000 |
Minority Interests | 6,000 | N/A | 16,000 | 9,000 | 2,000 |
Net Income | $774,000 | $1,355,000 | $2,047,000 | $3,039,000 | $-171,000 |
EPS Basic Total Ops | 0.13 | 0.22 | 0.34 | 0.49 | -0.03 |
EPS Basic Continuous Ops | 0.13 | 0.22 | 0.34 | 0.49 | -0.02 |
EPS Diluted Total Ops | 0.13 | 0.22 | 0.33 | 0.49 | -0.03 |
EPS Diluted Continuous Ops | 0.13 | 0.22 | 0.33 | 0.49 | -0.03 |
EBITDA(a) | $3,305,000 | $4,417,000 | $4,864,000 | $5,316,000 | $3,258,000 |